Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
55.50    0.50 (0.91%)
Bid:
54.00
Ask:
57.00
Spread: 3.00 (5.556%)
Market Cap: £106.48m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Business Update

4 Sep 2025 07:00

RNS Number : 9226X
Iofina PLC
04 September 2025
 

 

4 September 2025

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Record Monthly Iodine Production 

Cash Reserve Increase of $1.8 million

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to report that the 74.3MT of crystalline iodine produced at the Company's IOsorb® plants in August 2025 was the highest single month of iodine production. The Company's plants are currently operating efficiently and have not experienced extreme weather conditions. This, combined with the recent addition of IO#11 to the Iofina Resources portfolio, which has operated as expected, has contributed to the record production. Iofina owns and operates eight IOsorb® plants in two core areas, with five plants in NW Oklahoma and three plants in Central Oklahoma.

 

Additionally, the Company is pleased to announce that its cash reserve has increased by $1.8 million. Iofina Resources and Iofina Chemical have recently received Employee Retention Tax Credit ('ERTC') refunds of current net funds and interest received that total over $1.8m. The ERTC is a refundable tax credit for eligible businesses that retained employees and were affected during the COVID-19 pandemic. The Company retained a certified public accounting firm that specialised in tax audit to retain these credits. The Company is pleased to have received these credits for the difficult COVID-19 pandemic period, which included the shutdown or reduction of certain processes due to negative pricing and moratoriums. Further details will be provided in the Group's interim report later this month.

 

Commenting, President and CEO, Dr. Tom Becker, stated:

"The Group's recent record production levels are a statement of the hard work by all our dedicated employees. Our commitment to keeping our employees in work during the COVID-19 pandemic has been recognised with tax credits of over $1.8m.

 

"We continue to execute our growth strategy, recently adding IO#11 to our portfolio, and it is performing as expected. Moving ahead, the Company is focused on maximising production in our core areas and is looking to expand into new areas in the future as site contracts are being concluded, along with the completion of plant designs and enhancements for future iodine production."

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Iofina plc 

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

 

Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates eight producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

www.iofina.com

 

Follow Iofina's latest developments via its LinkedIn and X accounts.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBLGDCLUGDGUX
Date   Source Headline
19th May 20204:36 pmRNSPrice Monitoring Extension
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSPPP Loan Received
4th May 20207:00 amRNSIO#8 Brine Supply Update
14th Apr 20207:00 amRNSQ1 Market Update
2nd Apr 20207:00 amRNSDirectorate Change
26th Mar 20201:53 pmRNSWithdrawal of requisition for General Meeting
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20201:56 pmRNSClarification Regarding Media Reports
11th Mar 202012:08 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20207:30 amRNSBoard response to recent GM request
10th Mar 20207:00 amRNSRequisition of General Meeting
3rd Mar 20207:10 amRNSStatement re: press and social media reports
2nd Mar 202012:22 pmRNSHolding(s) in Company
25th Feb 202012:00 pmRNSMarket Update
10th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:15 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSMarket Update - Strong H2 2019
2nd Jan 202011:11 amRNSHolding(s) in Company
20th Dec 20197:00 amRNSTrading Update
14th Nov 20193:51 pmRNSHolding(s) in Company
14th Nov 20193:50 pmRNSHolding(s) in Company
12th Nov 20191:43 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSIofinaEX Hemp Seed Investment
14th Oct 20197:00 amRNSQ3 2019 Update
26th Sep 201910:00 amRNSHolding(s) in Company
25th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSTerms for IO#8 Finalised - Construction Commences
29th Aug 20194:41 pmRNSSecond Price Monitoring Extn
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.